analysts

Why Johnson & Johnson Stock Flopped Today
Motley Fool
Wed, 10/18/23 - 07:39 pm
JNJ
earnings
analysts
Biogen's Aduhelm still has blockbuster potential if everything breaks right: analyst
Fierce Pharma
Fri, 03/4/22 - 09:47 am
Biogen
Aduhelm
Alzheimer's disease
physicians
analysts
Biogen Alzheimer's Drug Headed For Unfavorable Vote, Says An Analyst's Mock Panel
Investors Business Daily
Mon, 10/19/20 - 10:53 am
Biogen
aducanumab
Alzheimer's disease
FDA
analysts
advisory panels
mock advisory panels
Sarepta's Lone Analyst Skeptic Takes On 22 Bulls With Renewed Warnings
Bloomberg
Mon, 08/19/19 - 10:28 am
Sarepta Therapeutics
analysts
Duchenne Muscular Dystrophy
Vyondys 53
Exondys 51
Mylan-Upjohn Merger Leaves Analysts Skeptical
Xtalks
Sat, 08/3/19 - 02:38 pm
analysts
M&A
Mylan
Pfizer
Upjohn
Why Valeant Pharmaceuticals Tumbled 10.9% Today
Motley Fool
Wed, 01/24/18 - 08:19 pm
Valeant Pharmaceuticals
analysts
Cancer Drug Developer NewLink Genetics Gets Push From Analysts
Minyanville
Wed, 12/21/11 - 09:12 pm
analysts
NewLink Genetics
pancreatic cancer
Will Biogen Idec Disappoint Analysts Next Quarter?
Motley Fool
Wed, 09/14/11 - 10:58 am
Biogen Idec
analysts
Analysts see an upside after market swings bludgeon biotechs
Fierce Biotech
Mon, 08/15/11 - 12:00 pm
biotech
analysts
Teva Analysts Stick to ‘Buy’ Ratings as Stock Repays Love With 41% Decline
Bloomberg
Thu, 08/11/11 - 02:02 pm
Teva Pharmaceuticals
analysts
Analyst ratings boost drug stocks
Marketwatch
Wed, 04/13/11 - 11:08 am
biotech
analysts
Regeneron
GTx
BioSante
Analysts say new RFP makes SIGA likely winner of gov't smallpox-drug contract; shares leap
Yahoo/AP
Tue, 02/22/11 - 05:59 pm
analysts
government contracts
SIGA technologies
Sanofi-Genzyme: What the Analysts Are Saying
Seeking Alpha
Thu, 02/17/11 - 07:58 am
analysts
M&A
Sanofi
Genzyme
Analysts Welcome Change at Pfizer’s Helm but Want More
Seeking Alpha
Mon, 12/13/10 - 10:07 am
Pfizer
Ian Read
analysts
GlaxoSmithKline - Upgrades & Downgrades
TheStreet.com
Mon, 10/25/10 - 10:52 am
GSK
analysts
downgrades
upgrades
Sanofi Likely to Shell out More for Genzyme: Analysts
CNBC
Mon, 10/4/10 - 10:07 am
analysts
Sanofi
M&A
hostile takeover
Genzyme
Analyst lowers rating on GlaxoSmithKline due to greater risk of Avandia withdrawals
Yahoo/AP
Wed, 09/15/10 - 09:21 am
Avandia
analysts
GSK
Amgen falls on analyst rating; indexes slip
Marketwatch
Mon, 08/16/10 - 11:49 am
Amgen
analysts
Avanir shares jump on analyst outlook
Yahoo/AP
Thu, 07/1/10 - 04:34 pm
Avanir
analysts
Analysts turn bearish on Roche's taspoglutide prospects
Fierce Biotech
Tue, 06/29/10 - 09:17 am
diabetes
taspoglutide
analysts
Roche